Consolidated Statements of Profit or Loss and Other Comprehensive Income
(In thousands of U.S dollars, except per share amounts) | |||||||||||
For the year ended
December 31, |
Three Months Ended
December 31, | ||||||||||
2022 | 2023 | 2022 | 2023 | ||||||||
Revenues | 43,633 | 56,314 | 12,104 | 14,454 | |||||||
Cost of revenues | 24,943 | 30,759 | 3,784 | 7,358 | |||||||
Cost of revenues - write-down of inventories and amortization of assets recognized in business combination and technology | 4,639 | 97 | 649 | 68 | |||||||
Total cost of revenues | 29,582 | 30,856 | 4,433 | 7,426 | |||||||
Gross profit | 14,051 | 25,458 | 7,671 | 7,028 | |||||||
Research and development expenses | 75,763 | 62,004 | 20,993 | 13,580 | |||||||
Sales and marketing expenses | 38,833 | 31,707 | 9,758 | 8,289 | |||||||
General and administrative expenses | 30,457 | 58,254 | 9,091 | 14,051 | |||||||
Other income, net | — | 1,627 | — | 1,627 | |||||||
Impairment losses on intangible assets | 40,523 | — | 40,523 | — | |||||||
Operating loss | (171,525 | ) | (124,880 | ) | (72,694 | ) | (27,265 | ) | |||
Finance income | 22,965 | 70,934 | 11,105 | 26,904 | |||||||
Finance expenses | 79,471 | 1,652 | 25,305 | 796 | |||||||
Loss before taxes on income | (228,031 | ) | (55,598 | ) | (86,894 | ) | (1,157 | ) | |||
Taxes expenses | (264 | ) | (62 | ) | (1,006 | ) | (183 | ) | |||
Loss for the period | (228,295 | ) | (55,660 | ) | (87,900 | ) | (1,340 | ) | |||
Loss attributable to non-controlling interests | (872 | ) | (1,110 | ) | (233 | ) | (291 | ) | |||
Loss attributable to owners | (227,423 | ) | (54,550 | ) | (87,667 | ) | (1,049 | ) | |||
Loss per share | |||||||||||
Basic loss per share | (0.88 | ) | (0.22 | ) | (0.34 | ) | (0.01 | ) | |||
Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss | |||||||||||
Foreign currency translation differences for foreign operations | (844 | ) | 2,368 | 1,507 | 2,024 | ||||||
Other comprehensive income items that will not be transferred to profit or loss | |||||||||||
Remeasurement of net defined benefit liability (IAS 19), net of tax | 2,508 | (1,801 | ) | (619 | ) | (741 | ) | ||||
Total other comprehensive income for the period | 1,664 | 567 | 888 | 1,283 | |||||||
Total comprehensive loss for the period | (226,631 | ) | (55,093 | ) | (87,012 | ) | (57 | ) | |||
Comprehensive loss attributable to non-controlling interests | (892 | ) | (1,088 | ) | (157 | ) | (258 | ) | |||
Comprehensive loss attributable to owners of the Company | (225,739 | ) | (54,005 | ) | (86,855 | ) | 201 | ||||